Agios Pharmaceuticals Head of Biometrics and Regulatory Affairs, Margarida Geraldes, PhD, discusses their adoption of the EU Clinical Trials Regulation (CTR), how to transition to the new regulation effectively and how CMOs can best partner with their regulatory colleagues.